Perrigo Company plc (PRGO) Research

Perrigo Company plc specializes in delivering readily available, non-prescription health and well-being products. Its core mission is to elevate personal health by empowering individuals to proactively manage or address common conditions without professional intervention. The company's operations are strategically divided into two main segments: Consumer Self-Care Americas and Consumer Self-Care International. The Consumer Self-Care Americas division is primarily focused on the creation, production, promotion, and sale of private label self-care products. These offerings span a diverse range of categories, including remedies for upper respiratory issues, pain relief and sleep aids, digestive health, nutritional items (such as vitamins, minerals, and supplements), healthy lifestyle products, skincare, personal hygiene, and oral self-care. This segment serves markets across the United States, Mexico, Canada, and South America. Its product portfolio includes well-known brands like Prevacid 24HR, Good Sense, Zephrex D, ScarAway, Plackers, Rembrandt, Steripod, Firefly, REACH, Dr. Fresh, and Burt's Bees. Conversely, the Consumer Self-Care International segment is dedicated to developing, manufacturing, marketing, and distributing consumer health brands. These products reach consumers through a comprehensive distribution network that includes pharmacies, wholesalers, drugstores, grocery retailers, and para-pharmacies. This segment operates in approximately 23 countries, with a primary focus on the European market. Beyond its own product lines, Perrigo also offers specialized contract manufacturing services. Established in 1887, Perrigo Company plc maintains its corporate headquarters in Dublin, Ireland.

Market snapshot

Symbol
PRGO
Price
$10.25
Day change
+0.89%
Market cap
$1.4B
P/E ratio
-0.78x
52-week range
9.23-28.44
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Next earnings
in 2 months
Analyst price target
$36.20

Recent news

  • Mission Produce Posts Downbeat Q2 Earnings, Joins Ideaya Biosciences, Perrigo And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

    U.S. stock futures were higher this morning, with the Nasdaq futures gaining around 200 points on Tuesday.

  • Perrigo CEO Ousted Over Personal Conduct

    Perrigo Chief Executive Patrick Lockwood-Taylor has resigned after the board found his personal conduct had violated company code.

Peer companies

  • Alphatec Holdings, Inc. (ATEC)
  • Bausch Health Companies Inc. (BHC)
  • Amicus Therapeutics, Inc. (FOLD)
  • HUTCHMED (China) Limited (HCM)
  • Heartflow, Inc. Common Stock (HTFL)
  • LivaNova PLC (LIVN)
  • Surgery Partners, Inc. (SGRY)
  • Scholar Rock Holding Corporation (SRRK)

Recent insider activity

  • Parker Geoffrey M. — M-Exempt (976 shares) on 2026-06-12
  • Parker Geoffrey M. — F-InKind (469 shares) on 2026-06-12
  • Parker Geoffrey M. — A-Award (844 shares) on 2026-06-12
  • Parker Geoffrey M. — M-Exempt (976 shares) on 2026-06-12
  • Manzone Albert — A-Award (1069 shares) on 2026-06-12

Open Perrigo Company plc (PRGO) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.